tiprankstipranks
CSL (AU:CSL)
ASX:CSL
Australian Market
Want to see AU:CSL full AI Analyst Report?

CSL (CSL) Share Forecast & Price Target

980 Followers
See the Price Targets and Ratings of:

CSL Analyst Ratings

Moderate Buy
10Ratings
Moderate Buy
4 Buy
6 Hold
0 Sell
Based on 10 analysts giving stock ratings to
CSL
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CSL Stock 12 Month Forecast

Average Price Target

AU$163.77
▲(43.38% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for CSL in the last 3 months. The average price target is AU$163.77 with a high forecast of AU$207.00 and a low forecast of AU$133.00. The average price target represents a 43.38% change from the last price of AU$114.22.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"93":"AU$93","176":"AU$176","259":"AU$259","134.5":"AU$134.5","217.5":"AU$217.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":207,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$207.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":163.77100000000002,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$163.77</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":133,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$133.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[93,134.5,176,217.5,259],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,123.06,129.5169230769231,135.97384615384615,142.43076923076924,148.8876923076923,155.3446153846154,161.80153846153846,168.25846153846155,174.7153846153846,181.1723076923077,187.6292307692308,194.08615384615385,200.5430769230769,{"y":207,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,123.06,126.19161538461539,129.32323076923078,132.45484615384615,135.58646153846155,138.71807692307692,141.84969230769232,144.9813076923077,148.1129230769231,151.24453846153847,154.37615384615387,157.50776923076924,160.63938461538464,{"y":163.77100000000002,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,123.06,123.82461538461538,124.58923076923077,125.35384615384615,126.11846153846155,126.88307692307693,127.64769230769231,128.4123076923077,129.1769230769231,129.94153846153847,130.70615384615385,131.47076923076924,132.23538461538462,{"y":133,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":258.694,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":206.005,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":196.257,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":176.217,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.291,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170.442,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.815,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.416,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.17,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.84,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.2,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":118.37,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.06,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetAU$207.00Average Price TargetAU$163.77Lowest Price TargetAU$133.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on AU:CSL
Jefferies
Jefferies
AU$119AU$146.5
Hold
28.26%
Upside
Reiterated
08/20/26
CSL (CMXHF) Gets a Hold from Jefferies
Ord Minnett Analyst forecast on AU:CSL
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
AU$123.3AU$152.5
Hold
33.51%
Upside
Reiterated
08/19/26
Ord Minnett Sticks to Their Hold Rating for CSL (CMXHF)
Morgan Stanley Analyst forecast on AU:CSL
Morgan Stanley
Morgan Stanley
AU$163AU$172
Buy
50.59%
Upside
Reiterated
08/19/26
Morgan Stanley Remains a Buy on CSL (CMXHF)
Jarden
AU$207
Buy
81.23%
Upside
Upgraded
08/19/26
Positive Report for CSL (CMXHF) from Jarden
UBS
AU$158AU$181
Buy
58.47%
Upside
Reiterated
08/19/26
CSL (CMXHF) Receives a Buy from UBS
Citi
AU$110AU$160
Hold
40.08%
Upside
Reiterated
08/19/26
Citi Keeps Their Hold Rating on CSL (CMXHF)
Morgans
AU$187.71
Buy
64.34%
Upside
Reiterated
08/19/26
Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (Other OTC: PMCUF) and CSL (Other OTC: CMXHF)
Bell Potter Analyst forecast on AU:CSL
Bell Potter
Bell Potter
AU$120AU$150
Hold
31.33%
Upside
Reiterated
08/19/26
Bell Potter Keeps Their Hold Rating on CSL (CMXHF)
Macquarie Analyst forecast on AU:CSL
Unknown Analyst
Macquarie
Not Ranked
Macquarie
AU$133
Hold
16.44%
Upside
Reiterated
08/18/26
Macquarie Sticks to Its Hold Rating for CSL (CMXHF)
RBC Capital Analyst forecast on AU:CSL
RBC Capital
RBC Capital
AU$108AU$148
Hold
29.57%
Upside
Reiterated
08/18/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Telix Pharmaceuticals (Other OTC: TLPPF), CSL (Other OTC: CMXHF) and Sol-Gel Technologies (NASDAQ: SLGL)
Canaccord Genuity Analyst forecast on AU:CSL
Canaccord Genuity
Canaccord Genuity
AU$180AU$106.31
Hold
-6.93%
Downside
Downgraded
05/12/26
Canaccord Genuity downgrades CSL (CMXHF) to a Hold
Goldman Sachs
AU$311AU$212.1
Buy
85.69%
Upside
Reiterated
10/29/25
Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)
CLSA
AU$315AU$275
Buy
140.76%
Upside
Reiterated
10/13/25
CLSA Keeps Their Buy Rating on CSL (CMXHF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on AU:CSL
Jefferies
Jefferies
AU$119AU$146.5
Hold
28.26%
Upside
Reiterated
08/20/26
CSL (CMXHF) Gets a Hold from Jefferies
Ord Minnett Analyst forecast on AU:CSL
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
AU$123.3AU$152.5
Hold
33.51%
Upside
Reiterated
08/19/26
Ord Minnett Sticks to Their Hold Rating for CSL (CMXHF)
Morgan Stanley Analyst forecast on AU:CSL
Morgan Stanley
Morgan Stanley
AU$163AU$172
Buy
50.59%
Upside
Reiterated
08/19/26
Morgan Stanley Remains a Buy on CSL (CMXHF)
Jarden
AU$207
Buy
81.23%
Upside
Upgraded
08/19/26
Positive Report for CSL (CMXHF) from Jarden
UBS
AU$158AU$181
Buy
58.47%
Upside
Reiterated
08/19/26
CSL (CMXHF) Receives a Buy from UBS
Citi
AU$110AU$160
Hold
40.08%
Upside
Reiterated
08/19/26
Citi Keeps Their Hold Rating on CSL (CMXHF)
Morgans
AU$187.71
Buy
64.34%
Upside
Reiterated
08/19/26
Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (Other OTC: PMCUF) and CSL (Other OTC: CMXHF)
Bell Potter Analyst forecast on AU:CSL
Bell Potter
Bell Potter
AU$120AU$150
Hold
31.33%
Upside
Reiterated
08/19/26
Bell Potter Keeps Their Hold Rating on CSL (CMXHF)
Macquarie Analyst forecast on AU:CSL
Unknown Analyst
Macquarie
Not Ranked
Macquarie
AU$133
Hold
16.44%
Upside
Reiterated
08/18/26
Macquarie Sticks to Its Hold Rating for CSL (CMXHF)
RBC Capital Analyst forecast on AU:CSL
RBC Capital
RBC Capital
AU$108AU$148
Hold
29.57%
Upside
Reiterated
08/18/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Telix Pharmaceuticals (Other OTC: TLPPF), CSL (Other OTC: CMXHF) and Sol-Gel Technologies (NASDAQ: SLGL)
Canaccord Genuity Analyst forecast on AU:CSL
Canaccord Genuity
Canaccord Genuity
AU$180AU$106.31
Hold
-6.93%
Downside
Downgraded
05/12/26
Canaccord Genuity downgrades CSL (CMXHF) to a Hold
Goldman Sachs
AU$311AU$212.1
Buy
85.69%
Upside
Reiterated
10/29/25
Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)
CLSA
AU$315AU$275
Buy
140.76%
Upside
Reiterated
10/13/25
CLSA Keeps Their Buy Rating on CSL (CMXHF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CSL

3 Months
David BaileyMorgan Stanley
Success Rate
10/23 ratings generated profit
43%
Average Return
+0.43%
Copying David Bailey's trades and holding each position for 3 Months would result in 43.48% of your transactions generating a profit, with an average return of +0.43% per trade.
1 Year
David BaileyMorgan Stanley
Success Rate
10/23 ratings generated profit
43%
Average Return
-3.67%
Copying David Bailey's trades and holding each position for 1 Year would result in 43.48% of your transactions generating a profit, with an average return of -3.67% per trade.
2 Years
David BaileyMorgan Stanley
Success Rate
8/23 ratings generated profit
35%
Average Return
-5.12%
Copying David Bailey's trades and holding each position for 2 Years would result in 34.78% of your transactions generating a profit, with an average return of -5.12% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CSL Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
11
14
12
9
2
Buy
8
1
0
4
8
Hold
10
14
19
23
20
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
29
29
31
36
30
In the current month, CSL has received 10 Buy Ratings, 20 Hold Ratings, and 0 Sell Ratings. CSL average Analyst price target in the past 3 months is 163.77.
Each month's total comprises the sum of three months' worth of ratings.

CSL Financial Forecast

CSL Earnings Forecast

Next quarter’s earnings estimate for CSL is AU$5.76 with a range of AU$5.55 to AU$6.06. The previous quarter’s EPS was AU$3.38. CSL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CSL has Performed in-line its overall industry.
Next quarter’s earnings estimate for CSL is AU$5.76 with a range of AU$5.55 to AU$6.06. The previous quarter’s EPS was AU$3.38. CSL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CSL has Performed in-line its overall industry.

CSL Sales Forecast

Next quarter’s sales forecast for CSL is AU$11.90B with a range of AU$11.73B to AU$11.98B. The previous quarter’s sales results were AU$10.55B. CSL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CSL has Performed in-line its overall industry.
Next quarter’s sales forecast for CSL is AU$11.90B with a range of AU$11.73B to AU$11.98B. The previous quarter’s sales results were AU$10.55B. CSL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CSL has Performed in-line its overall industry.

CSL Stock Forecast FAQ

What is AU:CSL’s average 12-month price target, according to analysts?
Based on analyst ratings, CSL’s 12-month average price target is 163.77.
    What is AU:CSL’s upside potential, based on the analysts’ average price target?
    CSL has 43.38% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CSL a Buy, Sell or Hold?
          CSL has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 6 hold ratings and 0 sell ratings.
            What is CSL’s share price target?
            The average share price target for CSL is 163.77. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is AU$207.00 ,and the lowest forecast is AU$133.00. The average share price target represents 43.38% Increase from the current price of AU$114.22.
              What do analysts say about CSL?
              CSL’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of CSL?
                To buy shares of AU:CSL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.